CUPR

1.4106.00%
RS

Ronald Sherman

Medical & Scientific Director

Dr. Ronald Sherman is Medical & Scientific Director of Cuprina Holdings (Cayman) Limited from September 2025. Dr. Sherman has experience in the field of biotherapy. After earning a BS in Entomology at UC Riverside, an MD at UCLA and completing his Internal Medicine Residency at UC Davis in 1987, he went on to obtain a Masters in Clinical Tropical Medicine at the London School of Hygiene and completed an Infectious Diseases Fellowship at UC Irvine in 1991, during which he began his clinical studies of wound care and maggot therapy. After continuing these studies for four years working at the Veterans Affairs Medical Center in Long Beach, CA, Dr. Sherman joined the faculty of UC Irvine, where for the next thirteen years he continued his research in maggot therapy and maggot biochemistry. In 2004, shortly after the FDA started regulating medicinal maggots as a medical device, he was granted FDA marketing clearance for the medical maggots produced in his laboratory. Dr. Sherman left UC Irvine in 2008 to devote his time to co-founding and overseeing a medical maggot laboratory (now known as Monarch Labs), supplying medical grade maggots to physicians throughout North America. Since 2003 Dr. Sherman has served as director of the non-profit, BioTherapeutics Education & Research Foundation, whose mission is to support patient care, education and research in maggot therapy, leech therapy and the other biotherapeutic modalities. He has also worked as an HIV Clinic physician at the Orange County Public Health Care Agency since 1997, delivering healthcare to the county’s uninsured.

公司職務